statins and glp 1 aggravate insulin resistance through reduced blood glucagon-like peptide-1 levels in a microbiota-dependent manner: Cell Metabolism 🫀 How Artery Plaque Changes

71 In the absence of structured nutrition and exercise efforts, loss of muscle and bone may be exacerbated by intermittent use of GLP-1s and weight regain or weight cycling, increasing risk of sarcopenic obesity

[DOI] [PMC free article] [PubMed] [Google Scholar] 79.Zhang L., Zhang L., Li L., Hlscher C

Mistake 3: Believing "it makes you go blind." Sudden vision loss (NAION) is a real but rare signal, it is absent in several large studies, and it is not confirmed to be caused by the drug (Liu 2025)

But it works differently than Januvia

The GLP-1 Agonist, Liraglutide, did not Stimulate Inflammatory mRNA Expression, but Stimulated Cell Proliferation of PSCs We next examined whether the GLP-1R agonist, liraglutide, stimulated inflammatory responses in PSCs (Figure 7a)

Enterolglucagon: A Specific Effect on Gastric Glands Isolated From the Rat Fundus